January 2017 Monthly Net Asset Value THE INFORMATION

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
53
January 2017 Monthly Net Asset Value

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS

NB Private Equity Partners Announces Monthly NAV Update for January 2017

20 February 2017

NB Private Equity Partners Limited ("NBPE" or the "Company"), a closed-end private equity investment company, today announced an updated Net Asset Value ("NAV") for the month ended 31 January 2017.

Key Highlights

  • Monthly and annual NAV development:
  Month 31 Jan 17 LTM
     
Total return NAV development per Share [1] 1.1% 13.7%
NAV development per Share 1.1% 9.8%
  • Following the $0.25 accrual of the January 2017 declared dividend, the 31 January 2017 NAV per Share of $15.36  decreased $0.07 from $15.43 NAV per Share at December 2016  
  • NBPE's NAV decrease of $3.7 million (an increase of $8.5 million excluding the dividend) during the month included:  
    • $10.3 million increase in NAV attributable to changes in the value of the investment portfolio
      • $12.6 million of unrealised gains attributable to the receipt of new valuation information, or $0.26 per share
      •  ($3.4) million of other unrealised gains, or ($0.07) per share, of which ($3.7) million was attributable to unrealised losses on public securities and $0.3 million was attributable to mark-to-market gains and realised adjustments
      • $1.1 million of accrued cash and payment in kind ("PIK") interest from the income investment portfolio, or $0.02 per share
    • ($12.2) million, or ($0.25) per Share, from the accrual for the January 2017 declared dividend
    • ($1.8) million decrease in NAV attributable to changes in other assets and liabilities during the month

Portfolio Valuation

The value of NBPE's private equity portfolio as of 31 January 2017 was based on the following information [2] :

  • 39% of the private equity fair value was valued as of 31 January 2017
    • 26% in private direct investments
    • 11% in public securities
    • 2% in credit-related fund investments  
  • 9% of the private equity fair value was valued as of 31 December 2016
    • 9% in private direct investments  
  • 52% of the private equity fair value was valued as of 30 September 2016
    • 35% in private direct investments
    • 17% in fund investments

Portfolio Commentary

During January, NBPE completed a new income investment in the first and second lien debt of Drive Medical, a manufacturer of medical mobility and rehabilitation products. NBPE also funded $0.6 million of follow-on investments to equity co-investments.

In terms of distributions, NBPE received $15.4 million from equity co-investments, primarily consisting of exit proceeds from the previously announced sale of Deltek. In addition, NBPE received $1.1 million of distributions, consisting of interest and principal payments, from income investments. Fund investments distributed $5.0 million to NBPE during January.

There were two additional noteworthy events during the month. First, as a result of the announced acquisition of a majority stake in Evans Network of Companies, NBPE increased its carrying value of its equity investment. Proceeds were received in February. Second, on 23 January 2017, NBPE declared its first 2017 dividend of $0.25 per Share, which represents an annualised yield of 3.3% on NAV and 3.9% on share price, based on the 17 February 2017 London Stock Exchange closing share price.

[1] Assumes reinvestment of dividends on the ex-dividend date and reflects cumulative returns over time period shown.

[2] Please refer to the valuation methodology section of the monthly report for a description of the Manager's valuation policy. While some valuation data is as of 31 December 2016 and 30 September 2016, the Manager's analysis and historical experience lead the Manager to believe that this approximates fair value at 31 January 2017.

For further information, please contact:

NBPE Investor Relations          +1 214 647 9593             Neustria Partners                     +44 20 3021 2580 Nick Henderson                         Nick.Henderson@neustriapartners.com Robert Bailhache                       Robert.Bailhache@neustriapartners.com Charles Gorman                        Charles.Gorman@neustriapartners.com

ABOUT NB PRIVATE EQUITY PARTNERS LIMITED NBPE is a closed-end private equity investment company with class A ordinary shares admitted to trading on Euronext Amsterdam and the Specialist Fund Segment of the London Stock Exchange. NBPE has  2017 ZDP shares admitted to trading on the Specialist Fund Segment of the London Stock Exchange and the Daily Official List of The Channel Islands Securities Exchange Authority Limited and 2022 ZDP Shares  admitted to trading on the Specialist Fund Segment of the Main Market of the London Stock Exchange. NBPE holds a diversified portfolio of direct equity investments, direct income investments and fund investments selected by the NB Alternatives group of Neuberger Berman, diversified across private equity asset class, geography, industry, vintage year, and sponsor.

ABOUT NEUBERGER BERMAN

Neuberger Berman, founded in 1939, is a private, independent, employee-owned investment manager. The firm manages equities, fixed income, private equity and hedge fund portfolios for institutions and advisors worldwide. With offices in 19 countries, Neuberger Berman's team is more than 1,900 professionals and the company has been named by Pensions & Investments as a Best Place to Work in Money Management for four consecutive years. Tenured, stable and long-term in focus, the firm fosters an investment culture of fundamental research and independent thinking. It manages $255 billion in client assets as of December 31, 2016. For more information, please visit our website at www.nb.com.

This press release appears as a matter of record only and does not constitute an offer to sell or a solicitation of an offer to purchase any security.

NBPE is established as a closed-end investment company domiciled in Guernsey. NBPE has received the necessary consent of the Guernsey Financial Services Commission and the States of Guernsey Policy Council. NBPE is registered with the Dutch Authority for the Financial Markets as a collective investment scheme which may offer participations in The Netherlands pursuant to article 2:66 of the Financial Markets Supervision Act (Wet op het financial toezicht). All investments are subject to risk. Past performance is no guarantee of future returns. The value of investments may fluctuate. Results achieved in the past are no guarantee of future results. This document is not intended to constitute legal, tax or accounting advice or investment recommendations. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. Statements contained in this document that are not historical facts are based on current expectations, estimates, projections, opinions and beliefs of NBPE's investment manager. Such statements involve known and unknown risks, uncertainties and other factors, and undue reliance should not be placed thereon. Additionally, this document contains "forward-looking statements." Actual events or results or the actual performance of NBPE may differ materially from those reflected or contemplated in such targets or forward-looking statements.

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...31dc6f3515

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 138

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 203

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 197

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 159

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
IEHP's Wellness Center Launch Faces Delay in California

Updated Category News Views 104

Unexpected Delay for IEHP's Community Hub Straight outta Rancho Cucamonga, we've got some news that'll have folks in San Bernardino holding their breath a little longer. The Inland Empire Health Plan (or IEHP if you're part of the 1.4 million served by them) had folks pumped for their new Community Wellness Center. But guess what? They had to slam the brakes on the grand...

Continue Reading
Dana Concludes Tender Offers for Senior Notes

Updated Category News Views 151

An Investor's Glance at Dana's Strategic Moves Dana Incorporated (NYSE: DAN) just pulled a bold move with their tender offers, snapping up a hefty $357,873,000 in outstanding principal on their senior notes. This isn’t just pocket change; folks holding out for securities can feel the tension of watching big numbers get shuffled around. You gotta wonder, what's the play...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 267

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 288

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 150

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading

Top 5 Most Recently Viewed Articles

BioXcel Therapeutics Secures Grant for BXCL501 Study in Stress Relief

Updated Category News Views 56

Exciting Development in Mental Health Treatment In a groundbreaking collaboration, BioXcel Therapeutics, Inc. (NASDAQ: BTAI) has joined forces with the University of North Carolina at Chapel Hill (UNC) thanks to a substantial grant from the U.S. Department of Defense. This grant aims to explore the effectiveness and safety of BXCL501, a novel treatment for acute stress...

Continue Reading
Eastern Michigan University Alumni Lead Research on Urban Wildlife

Updated Category News Views 197

Alumni Champions of Environmental Research In a remarkable tale of collaboration fueled by a shared passion for wildlife research, Eastern Michigan University alumni Dorothy Zahor and Kenneth Glynn came together to explore environmental issues through the lens of urban wildlife. Their dedication to the study of American robins has revealed fascinating insights into how...

Continue Reading
Verkada Appoints Micah Deriso to Strengthen Global Channel

Updated Category News Views 157

Verkada Strengthens Global Channel Operations Verkada, known for its innovative cloud-based physical security solutions, recently announced a strategic enhancement in its global channel operations with the appointment of Micah Deriso as Head of Global Channel. This strategic move aims to bolster Verkada's global partnerships and streamline its channel strategy. Meet Micah...

Continue Reading
Investigation Launched into Citi Trends, Inc. by Purcell & Lefkowitz

Updated Category News Views 211

Purcell & Lefkowitz LLP Investigates Citi Trends, Inc. Recently, Purcell & Lefkowitz LLP announced an investigation concerning Citi Trends, Inc. (NASDAQ: CTRN). This inquiry arises from concerns regarding the fiduciary duties of the directors amidst ongoing corporate actions. The aim is to determine if there have been any breaches that may affect shareholders....

Continue Reading
Prairie Operating Co. Advances with Shelduck South Pad Success

Updated Category News Views 125

Prairie Operating Co. Announces Successful Shelduck South Pad Completion Prairie Operating Co. (Nasdaq: PROP) has recently achieved a remarkable milestone with the timely completion of its Shelduck South pad in the DJ Basin. This accomplishment marks the successful culmination of the first phase of its development program for 2025, aiming for all production to be fully...

Continue Reading